Today, www.EquityLeader.com introduced research coverage of Mylan Inc. (NASDAQ: MYL) and CA, Inc. (NASDAQ: CA). Full research reports are available to readers at: www.EquityLeader.com/index.php?sm1=MYL&sm2=CA.

With markets in correction mode, investors are looking to quantify an accurate model, weighing positives and negatives of the months ahead. Upcoming negative pressures include China's slowdown, the European recession, the end of the Fed's Operation Twist stimulus program, continued geopolitical risks, election uncertainty, and potential 2013 budget bombshell of tax hikes and spending cuts. Meanwhile, positive offsets are driven by central banks (particularly China) cutting rather than hiking rates, deceleration in fuel and food prices, increase in consumer sentiment and resulting retail sales, signs of improvement in housing sales and new strength in auto production schedules.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Equity Leader has decided to cover Mylan Inc. for its current position within the healthcare industry. Mylan Inc. (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. The Company operates a specialty business, which is focused on respiratory, allergy and psychiatric therapies. A copy of this report detailing Mylan Inc. (NASDAQ: MYL) is available at: www.EquityLeader.com/index.php?sm1=MYL.

Equity Leader is also taking note of CA, Inc. for its changing role within the technology industry. CA, Inc. (CA) is an independent enterprise information technology (IT) management software and solutions company. CA develops and delivers software and services. The Company operates in three segments: mainframe solutions, enterprise solutions and services. To download free research on CA, Inc. (NASDAQ: CA) investors may visit: www.EquityLeader.com/index.php?sm2=CA.

About Equity Leader Whether you are a first time investor or seasoned market professional, Equity Leader provides the resources necessary to simplify your research process. Our focus has always been to empower investors with the information they need to make their own investment decisions.

Contact: Michael Westbrook Email Contact www.EquityLeader.com

Grafico Azioni Xtrackers California Mun... (NASDAQ:CA)
Storico
Da Giu 2024 a Lug 2024 Clicca qui per i Grafici di Xtrackers California Mun...
Grafico Azioni Xtrackers California Mun... (NASDAQ:CA)
Storico
Da Lug 2023 a Lug 2024 Clicca qui per i Grafici di Xtrackers California Mun...